Formosan Union Chemical Corp. AI Stock Analysis
Formosan Union Chemical Corp. (1709) AI Stock Analysis
Formosan Union Chemical Corp.
(TWSE:1709)
Formosan Union Chemical scores modestly above the mid-range. Its greatest strength is financial resilience: very low leverage (debt-to-equity of 0.18), a steadily shrinking debt load and consistently positive free cash flow give it real downside protection through the chemicals cycle. Weighing against that are declining revenue (down about 13% to NT$9.0bn), a roughly 20% fall in net income, compressed margins and operating cash flow that nearly halved, alongside a soft 6.6% ROE. Technically, the stock retains a solid long-term uptrend above its 100- and 200-day averages but has recently corrected below its shorter-term averages with negative MACD and oversold stochastics. Valuation is the final drag — a 21.3x P/E on falling earnings leaves limited cushion, only partly offset by a 2.38% dividend yield.
Formosan Union Chemical Corp. (1709) vs. SPDR S&P 500 ETF (SPY)
- Market Cap
- TWD 25.28B
- Dividend Yield
- 2.00%
- Average Volume (3M)
- 22.79M
- Price to Earnings (P/E)
- 25.1
- Beta (1Y)
- 0.61
- Revenue Growth
- 13.74%
- EPS Growth
- 193.25%
- Country
- TW
- Employees
- 427
- Sector
- General
- Sector Strength
- 55
- Industry
- Chemicals - Specialty
Formosan Union Chemical Corp. Business Overview & Revenue Model
Company Description
Formosan Union Chemical Corp. (FUCC), established in 1973 and headquartered in Taipei, Taiwan, operates as a key producer and supplier of chemical products throughout the region. The company's core chemical offerings include: Alkyl benzene, which ser...
Formosan Union Chemical Corp. Financial Statement Overview
Summary
A conservatively financed but cyclically pressured business. The balance sheet is the clear strength (score 78): debt reduced from NT$2.67bn to NT$1.65bn, debt-to-equity of just 0.18, and equity of NT$8.95bn funding roughly three-quarters of assets — though ROE has slipped to 6.6% from 13.1% in 2022, signalling weak capital productivity. The income statement is softer (score 52): revenue fell about 13% to NT$9.0bn, net income dropped around 20% to NT$586m, and gross margin of 14.9% sits far below the 23.2% peak, even if it improved slightly year over year and operating profit held firm. Cash flow (score 58) is positive but weakening — operating cash flow nearly halved to NT$563m and free cash flow fell roughly 28% to NT$497m, albeit converting at a healthy 88% of net income on very light capex. Net: low financial risk, but no growth or earnings momentum.
Income Statement
52NeutralBalance Sheet
78PositiveCash Flow
58Neutral| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 9.31B | 9.01B | 10.30B | 9.43B | 10.57B | 9.20B |
| Gross Profit | 2.00B | 1.34B | 1.47B | 1.16B | 1.95B | 2.14B |
| EBITDA | 1.62B | 888.70M | 1.20B | 799.60M | 1.63B | 1.25B |
| Net Income | 958.07M | 586.14M | 733.58M | 418.19M | 1.08B | 947.59M |
Balance Sheet | ||||||
| Total Assets | 12.34B | 12.12B | 12.78B | 12.09B | 13.27B | 11.59B |
| Cash, Cash Equivalents and Short-Term Investments | 1.18B | 1.11B | 601.16M | 724.37M | 1.57B | 898.36M |
| Total Debt | 1.01B | 1.65B | 1.91B | 2.33B | 2.67B | 2.16B |
| Total Liabilities | 3.09B | 2.91B | 3.44B | 3.84B | 4.72B | 3.69B |
| Stockholders Equity | 9.00B | 8.95B | 9.07B | 7.99B | 8.27B | 7.62B |
Cash Flow | ||||||
| Free Cash Flow | 583.76M | 496.68M | 686.22M | 737.06M | 1.04B | 495.64M |
| Operating Cash Flow | 664.85M | 563.30M | 1.07B | 796.34M | 1.13B | 609.79M |
| Investing Cash Flow | 232.55M | 248.53M | -245.30M | 15.31M | -23.28M | -39.14M |
| Financing Cash Flow | -1.10B | -759.89M | -862.96M | -1.53B | -550.93M | -885.14M |
Formosan Union Chemical Corp. Peers Comparison
Overall Rating
TW:172363Neutral
TW:171460Neutral
TW:170957Neutral
TW:210350Neutral
TW:171144Neutral
TW:131230Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 63Neutral | TWD 16.23B | 20.11 | ― | 2.62% | 7.82% | 10.83% | |
| 60Neutral | TWD 15.46B | 13.73 | ― | 1.11% | 48.25% | 238.60% | |
| 57Neutral | TWD 21.75B | 25.05 | ― | 2.00% | 13.74% | 193.25% | |
| Sector * | 55Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
| 50Neutral | TWD 19.40B | 8.40 | ― | 1.13% | 9.79% | 2185.39% | |
| 44Neutral | TWD 21.66B | 270.82 | ― | 0.80% | -2.22% | 33.13% | |
| 30Underperform | TWD 19.04B | -3.05 | ― | ― | 40.97% | -18.15% |
* General Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| TW:1709 | Formosan Union Chemical Corp. | 50.10 | 33.74 | 206.31% | |
| TW:1312 | Grand Pacific Petrochemical Corp. | 12.55 | 1.55 | 14.09% | |
| TW:1711 | Everlight Chemical Industrial Corporation | 37.40 | 18.46 | 97.50% | |
| TW:1714 | Ho Tung Chemical Corp. | 16.20 | 7.85 | 94.04% | |
| TW:1723 | China Steel Chemical Corporation | 70.60 | -7.51 | -9.61% | |
| TW:2103 | TSRC Corporation | 23.85 | 9.29 | 63.79% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 09, 2026
